Trial
NCT02494713
Hormonal Therapy and Chemotherapy Followed by Prostatectomy in Patients With Prostate Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
The University of Texas Health Science Center, Houston
Collaborators
—
Condition
Prostate Cancer
Intervention
Degarelix
Why stopped
slow enrollment; resource re-allocation
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-11-27